Baruch Brenner

This study tested whether adding two drugs, nivolumab and cetuximab, to standard chemoradiation helps shrink advanced esophageal cancer before surgery. Twelve people who had not been treated before took part. The goal was to see if the cancer completely disappeared after treatmen…

This study tests whether adding the immunotherapy drug nivolumab to standard chemotherapy and radiation can improve outcomes for people with locally advanced rectal cancer. About 29 participants who have not had prior treatment will receive the combination before surgery. The mai…